NDAQ:ENSC - Post Discussion
Post by
whytestocks on Jan 23, 2024 10:00am
Ensysce Biosciences Announces FDA Breakthrough Therapy Desig
Just In: $ENSC Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR~ FDA acknowledges significant potential impact of MPAR's oral overdose protection ~ SAN DIEGO, CA / ACCESSWIRE / January 23, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug s...
ENSC - Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
Be the first to comment on this post